Trial Profile
Clinical research of Alesion ophthalmic solution in patients with seasonal allergic conjunctivitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Epinastine (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- 06 Jan 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 09 May 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 08 Jan 2014 New trial record